Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. (Q46498636)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 January 2014

Language	Label	Description	Also known as
English	Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.	scientific article published on 10 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rosalinde Masereeuw

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Azza A K El-Sheikh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jan B Koenderink

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Alfons C Wouterse

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Petra H H van den Broek

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vivienne G M Verweij

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

10 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

164

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

46-56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486136%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Reviewing the evidence for de novo immunosuppression with sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Use of mycophenolic acid in non-transplant renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Effect of cyclosporine on mycophenolic acid area under the concentration-time curve in pediatric kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Influence of cyclosporine on the serum concentration and biliary excretion of mycophenolic acid and 7-O-mycophenolic acid glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Mechanisms of renal anionic drug transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport-deficient (TR-) rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Species differences in UDP-glucuronosyltransferase activities in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Can xipamide or tacrolimus inhibit the glucuronidation of mycophenolic acid in rat liver slices?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2014.01.006

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46498636&oldid=1578271790"